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Platelet-activating factor (PAF) is a phospholipid, intermediate in its structure between diacyl- and lyso- 
phospholipids. The reorientation of this highly bioactive compound to the inner membrane layer of human 
erythrocytes after its primary incorporation into the outer membrane layer has been studied. Reorientation 
was shown to be a slow process with an initial rate of only 0.012 h-*. It does not depend on energy supply. 
From the steady-state distribution of PAF between inner and outer membrane layers. after very long incu- 
bation times (4&50 h), a preference of PAF for the outer membrane layer analogous to that of endogenous 
lecithin is derived. Our data indicate that the process of simple transbilayer eorientation of PAF is probably 
too slow to account for very fast transmembrane signal transmission or for the fast uptake and metabolism 
observed in certain cell types. 
Platelet-activating factor Erythrocyte membrane Flip- Flop 
1. INTRODUCTION 
1-Alkyl-2-acetyl-sn-glycerol-3-phosphochohne is 
known to induce rapid aggregation of blood 
platelets and secretion of granular constituents 
from the cells [1,2]. It owes the name platelet- 
activating factor (PAF) to this property. PAF is 
released from platelets, basophilic and neutro- 
philic leucocytes and macrophages upon stimula- 
tion [3]. On the other hand, PAF causes chemo- 
taxis, enhanced adhesiveness, aggregation and 
degranulation [4,5] of polymorphonuclear leuco- 
cytes, induces the oxidative burst in macrophages 
[6], produces contraction of ileum smooth muscle, 
diminishes coronary blood flow and induces ana- 
phylaxis [3]. The platelet-activating effect of PAF 
is highly specific and depends on: (i) the ether- 
bonded I-alkyl chain; (ii) a short fatty acid (acetyl 
or propionyl) or alkyl chain at the 2 position; and 
(iii) its phosphorylcholine head group [7-lo]. 
* To whom correspondence should be addressed 
Recently, specific high-affinity binding sites for 
PAF have been demonstrated on platelet and 
smooth muscle membranes [ 1 l-141. Receptor 
binding of PAF is thought to induce phosphoino- 
sitide breakdown by phospholipase C and thereby 
to activate Ca*+-calmodulin-dependent kinase and 
protein kinase C [IS171. 
Investigations of a direct action of PAF on in- 
tracellular processes, of the rate of its uptake by 
cells and its subsequent metabolization, as well as 
of the rate of its release from activated cells are 
hampered by the lack of information on the rate of 
transmembrane movement of PAF (either by sim- 
ple transbilayer reorientation or protein- 
mediated). One aim of this work was therefore to 
measure the rate of transmembrane reorientation 
of PAF using the erythrocyte as a model system. In 
addition it was intended to check whether PAF 
might serve as an analogue of diacylphospha- 
tidylcholines for the quantiification of transbilayer 
mobility of phospholipids using a procedure 
previously elaborated for lysophospholipids 
[18,19]. PAF has the advantage over lyso- 
Published by Elsevrer Science Publishers B. V. (Biomedical Divisron) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 311 
Volume 198, number 2 FEBS LETTERS March 1986 
phospholipids that it is less amenable to enzymatic 
and nonenzymatic conversions. First, it has an 
ether-bonded alkyl chain instead of an ester at 
position 1 of the glycerol backbone, which is 
therefore not susceptable to hydrolysis [18]. 
Second, it has an acetyl group in the 2-position of 
glycerol, which still enables the quantification of 
transmembrane reorientation by its extraction 
from the membrane with albumin, but should pre- 
vent conversion of PAF to long-chain diacyl- 
lecithins by acylation. 
2. MATERIALS AND METHODS 
Heparinized human blood was obtained from 
the local blood bank. Erythrocytes were isolated 
by centrifugation, the buffy coat removed and 
erythrocytes washed three times with saline. PAF, 
l-O-[3H]octadecyl-2-acetyl-sn-glycero-3-phospho- 
choline (spec. act. 90 Ci/mmol or 3.33 
TBq/mmol), was obtained from Amersham, 
Braunschweig. 50 ,~l packed erythrocytes were 
suspended in 950 ~1 of a medium containing 
(mmol.l-‘): 1 KC1 (90), NaCl (45), NazHP04 
/NaH2P04 (12.5) and sucrose (44) (medium A, pH 
7.4). Subsequently, 10 ~1 labelled PAF (50 nCi) 
from a stock solution in methanol were added and 
the suspension incubated for 5 min at 22°C to in- 
corporate about 400 molecules of PAF per cell into 
the outer membrane layer. Following centrifuga- 
tion (5000 x g, 10 min), cells were suspended in 10 
vols medium A containing gentamycin (0.1 mg/ml 
medium) to prevent bacterial growth. Essentially 
no PAF (< 2%) was contained in the medium. A 
parallel suspension was incubated in the presence 
of glucose (5 mmol.l-‘). The phosphate content of 
this medium was twice that of medium A. After 
various periods of incubation (up to 50 h), 50 ~1 
samples were centrifuged, the erythrocytes washed 
once with medium A and the fraction of PAF in 
the outer layer quantified by 3 sequential albumin 
extractions at 22°C as described [18,19]. To detect 
metabolic conversions of PAF, 100 ~1 of the cell 
suspension were centrifuged, the erythrocytes 
hemolysed with 2 vols Hz0 and lipids extracted 
and separated by thin-layer chromatography on 
silica plates using chloroform-methanol-acetic 
acid-water (60:30:12:2) as described in [18]. Spots 
containing PAF (Rr = 0.19) and lecithin 
(Rf=0.37) were scraped from the plates and their 
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radioactivity quantified by liquid scintillation 
counting. 
3. RESULTS AND DISCUSSION 
The transbilayer reorientation of PAF in the 
erythrocyte membrane can be quantified by its loss 
of extractability by albumin, analogous to the 
method previously elaborated for phospholipids. 
PAF, however, could be extracted less readily than 
lysolecithin at 0°C. Two sequential treatments of 
cells with 1.5% albumin at 22°C for 2 min, im- 
mediately after incorporation of PAF into the 
membrane, resulted in extraction of 98% of PAF 
from the cells. Specific binding of PAF to certain 
membrane constituents seems rather unlikely, 
since the same small inextractable fraction was 
found when lOOO-times higher amounts of PAF 
were incorporated. The remaining 2% could not be 
extracted by increasing the albumin concentration, 
raising the extraction temperature or extending the 
extraction period. There fore the reorientation 
kinetics were corrected for this very small in- 
extractable fraction. As shown in fig.lA, the rate 
of reorientation of PAF from the outer to inner 
membrane layer of the erythrocyte is slow. From 
the initial rate of increase of the inextractable frac- 
tion of PAF (at a fractional reorientation of < 5%) 
one can calculate a rate constant for the reorien- 
tation process of 0.012 h-‘. This rate is somewhat 
lower than that of palmitoyllysolecithin (0.019 h-’ 
[181). 
In the presence of glucose the nonextractable 
fractions of PAF after 25 h of incubation were 
consistently higher than in the absence of glucose. 
The further analysis of this observation led to the 
finding that PAF-derived radioactivity is incor- 
porated into the lecithin fraction and that this in- 
corporation is dependent on the availability of 
energy supply (fig.lB). These findings make it like- 
ly that the acetyl group of PAF is slowly removed 
by hydrolysis and that the resulting free -OH group 
is re-esterified by long-chain fatty acids, par- 
ticularly in the presence of energy supply. Such an 
enzymatic system was recently described for 
platelets. In these cells, PAF is rapidly converted 
into long-chain ether analogues of lecithins by 
means of the combined action of a cytoplasmic 
hydrolase and an inner membrane surface bound 
acyltransferase system [21-231. Since phospho- 
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Fig.1. (A) Time-dependent increase of the fraction of 
PAF nonextractable by albumin. 3H-labelled PAF was 
incorporated into the outer membrane layer of human 
erythrocytes. Reorientation to the inner membrane layer 
in the absence or presence of glucose was followed by 
measuring the time-dependent decrease of extractability 
of PAF by albumin. (B) Time-dependent incorporation 
of PAF-derived radioactivity into lecithin. Incorpora- 
tion of radioactivity into the membrane lecithin fraction 
was quantified after lipid extraction and separation of 
lecithin from PAF by thin-layer chromatography. (C) 
Time-dependent increase of the fraction of PAF in the 
lipids with two long chains are not extractable by 
albumin, higher acylation rates in the presence of 
glucose cause a higher fraction of nonextractable 
radioactivity. After correction for acylation no 
significant difference between incubations with 
and without glucose is obtained (fig.lC). The only 
deviation was observed after very long incubations 
(50 h) in the absence of glucose, where the varia- 
tion of the data was rather high and nonextractable 
fractions were higher than those in the presence of 
glucose. This observation may be explained by 
hemolysis of the cells in the absence of glucose 
after these long incubation periods in salt medium. 
Using the formula fl/2 = 0.693/k x q [18], 
where q is the inner-leaf fraction of the total 
radioactivity, and a value of 0.012 h-’ (see above) 
as a first approximation for the initial rate con- 
stant (k), one can calculate half-time (f4 of 
reorientation assuming various steady-state 
distributions of PAF between the inner and outer 
membrane layers [9]. The best fit to the data could 
be obtained from a q value of 0.3 resulting in a 
half-time (for a 2-compartment system) of 17 h. 
After this time period the fraction of PAF in the 
inner layer (relative to total membrane-bound 
PAF) should be 0.15 which fits the curve of fig. 1C 
very well. A q value of 0.5 would give an inextrac- 
table fraction of 0.25 after 29 h (the cl/z for this 
ratio), which is significantly higher than the value 
corresponding to the curve after this time period. 
Our data therefore indicate a preference of PAF 
for the outer membrane layer similar to that of ex- 
ogenous lysolecithin [ 181 and endogenous lecithin 
WI. 
Our present data and previous results 
demonstrate, that the transbilayer eorientation of 
PAF and that of palmitoyllysolecithin in the 
inner membrane layer. The ratio q of PAF in the inner 
membrane layer to total membrane bound PAF was 
calculated from the fraction of nonextractable PAF (cf. 
A) after correction for acylation (cf. B) by the following 
equation: 
q = (nonextractable radioactivity - radioactivity in 
lecithin)/(total radioactivity - radioactivity in lecithin) 
Data of experiments in the absence (0) and presence (0) 
of glucose. The data represent mean values f SD for 
3-5 experiments. 
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erythrocyte membrane are both slow processes 
with half-times of 17 and 11 h, respectively [18]. If 
these slow rates are taken to reflect the ‘simple’, 
nonmediated movement across the lipid bilayer of 
nonspecialized biological membranes, it is im- 
mediately evident that the transmembrane signal 
transduction in cells stimulated by this transmitter 
requires an exofacial receptor. Moreover, our data 
suggest hat in cells which take up PAF rapidly a 
selective transfer system, presumably involving 
proteins, must be operative. This is presumably 
true, e.g. for platelets. They take up PAF at a high 
rate (fill < 1 h), much faster than lyso-PAF and 
convert it into long-chain ether lecithin [21-231. 
Irrespective of these physiological aspects, PAF 
might become a promising tool for studies on the 
simple, nonmediated flip-flop of phospholipids in 
biological membranes. The use of lysophospho- 
lipids for this purpose is hampered to some extent 
by their acylation to diacylphospholipids, which as 
yet has proved to be unsuppressible in all 
erythrocytes. In the case of PAF, prevention of the 
hydrolytic cleavage of the acetyl residue in position 
2 would forestall the transformation of the 
molecule. The blockage of hydrolysis of PAF by 
phenylmethylsulfonyl fluoride was reported [22] 
while this manuscript was in preparation. 
ACKNOWLEDGEMENTS 
The authors are indebted to Mrs H. Thomas for 
secretarial help, to Mr F.-J. Kaiser for 
photographical work and to the Deutsche 
Forschungsgemeinschaft (SFB 16O/C3) for finan- 
cial support. 
151 
El 
171 
PI 
[91 
[lOI 
1111 
[121 
[I31 
1141 
1151 
[I61 
1171 
1181 
1191 
PO1 
REFERENCES 
111 
121 
[31 
[41 
314 
Demopoulos, C.A., Pinckard, R.N. and Hanahan, 
D.J. (1979) J. Biol. Chem. 254, 9355-9358. 
Benveniste, J., Tence, M., Varenne, P., Bidault, 
J., Boullet, C. and Polonsky, J. C.R. (1979) CR 
Acad. Sci. Ser. D 289, 1037-1040. 
Snyder, F. (1982) Ann. Rep. Med. Chem. 17, 
243-25 1. 
Shaw, J.O., Pinckard, R.N., Ferrigni, K.S., 
MacManus, L.M. and Hanahan, D.J. (1981) J. 
Immunol. 127, 1250-1255. 
WI 
WI 
t231 
~241 
O’Flaherty, J.T., Wykle, R.L., Miller, C.H., 
Lowis, J.C., Waite, M., Bass, D.A., McCall, C.E. 
and De Chatelet, L.R. (1981) Am. J. Pathol. 103, 
70-78. 
Hartung, H.-P., Parnham, M.J. H., Winkelman, 
J., Englberger, W. and Hadding, U. (1983) Int. J. 
Immunopharmacol. 5, 115-121. 
O’Flaherty, J.T., Wykle, R.L., Miller, C.H., 
Lewis, J.C., Waite, M., Bass, D.A., McCall, C.E. 
and De Chatelet, L.R. (1981) Am. J. Pathol. 103, 
70-79. 
Hanahan, D.J., Munder, P.G., Satouchi, K., 
McManus, L. and Pinckard, R.N. (1981) Biochem. 
Biophys. Res. Commun. 99, 183-188. 
Wykle, R.L., Miller, C.H., Lewis, J.C., Schmitt, 
J.D., Smith, J.A., Surles, J.R., Piantadosi, C. and 
O‘Flaherty, J.T. (1981) Biochem. Biophys. Res. 
Commun. 100, 1651-1658. 
Satouchi, K., Pinckard, R.N., McManus, L.M. 
and Hanahan, D.J. (1981) J. Biol. Chem. 256, 
4425-4432. 
Hwang, S.-B., Lee, C.-S. C. Cheah, M.J. and 
Shen, T.Y. (1983) Biochemistry 22, 4756-4763. 
Valone, F.H. (1984) Immunology 52, 169-174. 
Kloprogge, E. and Akkerman, J.W.N. (1984) 
Biochem. J. 223, 901-909. 
Hwang, S.B., Lee, C.S.C., Cheat, M.J. and Tyler 
(1983) Biochemistry 22, 4756. 
MacIntyre, D.E. and Pollock, W.K. (1983) 
Biochem. J. 212, 433-437. 
Shukla, S.D. and Hanahan, D.J. (1983) Arch. 
Biochem. Biophys. 227, 626-629. 
Shukla, S.D., Buxton, D.B., Olson, M.S. and 
Hanahan, D.J. (1983) J. Biol. Chem. 258, 
10202-10214. 
Bergmann, W.L., Dressler, V., Haest, C. W.M. 
and Deuticke, B. (1984) Biochim. Biophys. Acta 
272, 328-336. 
Bergmann, W.L., Dressler, V., Haest, C.W.M. 
and Deuticke, B. (1984) Biochim. Biophys. Acta 
769, 390-398. 
Verkleij, A.J., Zwaal, R.F.A., Roelofsen, B., 
Comfurius, P., Kastelijn, D. and Van Deenen, 
L.L.M. (1973) Biochim. Biophys. Acta 323, 
178-193. 
Touqui, L., Jacquemin, C. and Bargaftig, B.B. 
(1983) Biochem. Biophys. Res. Commun. 110, 
890-893. 
Touqui, L., Jacquemin, C., Dumarey, C. and 
Vargaftig, B.B. (1985) Biochim. Biophys. Acta 
833, 111-118. 
Malone, B., Lee, T.-C., Snyder, F. (1985) J. Biol. 
Chem. 260, 1531-1534. 
Lachachi, H., Plantavid, M., Simon, M.-F., Chap, 
H., Braquet, P. and Douste-Blazy, L. (1985) 
Biochem. Biophys. Res. Commun. 132, 460-466. 
